Bernard Fisher
#20,423
Most Influential Person Now
Biologist
Bernard Fisher 's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Bernard Fisher Influential?
(Suggest an Edit or Addition)According to Wikipedia, Bernard Fisher was an American surgeon and a pioneer in the biology and treatment of breast cancer. He was a native of Pittsburgh. He was Chairman of the National Surgical Adjuvant Breast Project at the University of Pittsburgh School of Medicine. His work established definitively that early-stage breast cancer could be more effectively treated by lumpectomy, in combination with radiation therapy, chemotherapy, and/or hormonal therapy, than by radical mastectomy.
Bernard Fisher 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
- Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. (1999) (5389)
- Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. (1998) (2102)
- Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. (1985) (2054)
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. (1997) (1718)
- Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. (1989) (1558)
- A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. (1989) (1427)
- Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. (1985) (1318)
- Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. (2002) (1271)
- Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. (2005) (1251)
- Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. (2002) (1239)
- Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. (2001) (1237)
- Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. (1995) (1131)
- The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. (2003) (1080)
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update (1983) (1010)
- Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. (1988) (1003)
- Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial (1999) (985)
- Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27. (2006) (907)
- Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. (1996) (884)
- Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. (1994) (877)
- Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. (1993) (821)
- The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) (1975) (777)
- Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS) (1986) (767)
- Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. (2001) (751)
- 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. (1975) (704)
- Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. (2005) (695)
- Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. (2011) (680)
- erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. (1998) (674)
- Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. (1994) (662)
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. (1993) (656)
- Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. (1998) (637)
- Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. (2001) (637)
- Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. (1990) (623)
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials (2018) (614)
- Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowe (1990) (593)
- Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. (2002) (574)
- Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. (2010) (543)
- Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. (2001) (518)
- Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. (1997) (512)
- Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. (2000) (506)
- Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. (2005) (488)
- Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. (1999) (469)
- Cancer of the breast: Size of neoplasm and prognosis (1969) (455)
- Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. (1983) (445)
- Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. (1999) (444)
- The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. (1994) (437)
- Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. (2006) (433)
- The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. (1981) (431)
- Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. (1988) (430)
- Effect of surgical removal on the growth and kinetics of residual tumor. (1979) (416)
- Portacaval shunt in the rat. (1961) (409)
- Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. (2009) (400)
- Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. (1988) (399)
- Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized clinical trial (1977) (391)
- Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 (1999) (385)
- A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum (1997) (384)
- Pathologic findings from the national surgical adjuvant breast project (protocol 6). Relation of local breast recurrence to multicentricity (1986) (383)
- A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. (1989) (379)
- Surgical Adjuvant Chemotherapy in Cancer of the Breast: Results of a Decade of Cooperative Investigation (1968) (379)
- Presence of a growth-stimulating factor in serum following primary tumor removal in mice. (1989) (378)
- Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. (1975) (365)
- Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. (1980) (364)
- Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials (2004) (348)
- National Surgical Adjuvant Breast and Bowel Project (2005) (341)
- Pathobiology of preoperative chemotherapy (2002) (338)
- Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. (1988) (325)
- Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. (1997) (325)
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. (1990) (302)
- Postoperative Radiotherapy in the Treatment of Breast Cancer: Results of the NSABP Clinical Trial (1970) (302)
- Treatment of primary breast cancer with chemotherapy and tamoxifen. (1981) (296)
- Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17. Intraductal carcinoma (ductal carcinoma in situ) (1995) (291)
- Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. (1990) (283)
- Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants (1993) (279)
- Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. (1983) (274)
- Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure (1984) (262)
- Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. (2001) (260)
- Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. (2002) (250)
- Detection and significance of occult axillary node metastases in patients with invasive breast cancer (1978) (249)
- Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. (1992) (242)
- The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings (1980) (236)
- Fifteen‐year prognostic discriminants for invasive breast carcinoma (2001) (230)
- Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and (1996) (226)
- Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25. (1999) (226)
- Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. (2003) (225)
- Microvascular surgical techniques in research, with special reference to renal transplantation in the rat (1965) (211)
- Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. (1986) (209)
- Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. (1995) (208)
- The Prognostic Value of the Modifications of the Dukes' C Class of Colorectal Cancer: An Analysis of the NSABP Clinical Trials (1986) (208)
- Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. (1985) (205)
- Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. (1990) (204)
- Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). V. significance of axillary nodal micro‐ and macrometastases (1978) (204)
- Tamoxifen for prevention of breast cancer. (1999) (197)
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials (2019) (197)
- Association of tamoxifen and uterine sarcoma. (2002) (196)
- L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU) (1977) (190)
- Histologic grading of breast cancer. (1980) (185)
- Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials (2004) (180)
- Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer (1975) (173)
- Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer (1980) (170)
- Experimental Evidence in Support of the Dormant Tumor Cell (1959) (166)
- The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. (1983) (164)
- The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. (1984) (164)
- A Portal Blood Factor as the Humoral Agent in Liver Regeneration (1971) (163)
- Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (2004) (163)
- Findings from NSABP protocol no. b‐04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial‐central breast cancers (1981) (161)
- Coronary heart disease mortality and adjuvant tamoxifen therapy. (1997) (160)
- Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. (1986) (155)
- Pathologic findings from the national surgical adjuvant breast project (protocol no. 4): XI. Bilateral breast cancer (1984) (154)
- Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. (1989) (153)
- Number of lymph nodes examined and the prognosis of breast carcinoma. (1970) (152)
- An Analysis of Survival and Treatment Failure Following Abdominoperineal and Sphincter‐saving Resection in Dukes' B and C Rectal Carcinoma: A Report of the NSABP Clinical Trials (1986) (152)
- Conservative management of intraductal carcinoma (DCIS) of the breast (1991) (152)
- Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. (1989) (151)
- Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. (1980) (150)
- Experimental Studies of Factors Influencing Hepatic Metastases: III. Effect of Surgical Trauma with Special Reference to Liver Injury (1959) (145)
- From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century. (1999) (145)
- Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. (2001) (144)
- Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B‐17: Five‐year observations concerning lobular carcinoma in situ (1996) (144)
- The interrelationship of hematogenous and lymphatic tumor cell dissemination. (1966) (140)
- The evolution of paradigms for the management of breast cancer: a personal perspective. (1992) (137)
- Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer (1989) (128)
- Transmigration of Lymph Nodes by Tumor Cells (1966) (128)
- Pathologic findings from the national surgical adjuvant breast project (protocol 4): Discriminants for 15‐year survival (1993) (127)
- Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival (1996) (121)
- Lumpectomy for breast cancer: an update of the NSABP experience. National Surgical Adjuvant Breast and Bowel Project. (1992) (121)
- 1‐Phenylalanine mustard (L‐PAM) in the management of premenopausal patients with primary breast cancer. Lack of association of disease‐free survival with depression of ovarian function (1979) (119)
- Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). (1989) (118)
- Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. (1987) (117)
- Studies concerning the regional lymph node in cancer. I. Initiation of immunity (1971) (116)
- Barrier function of lymph node to tumor cells and erythrocytes. I. Normal nodes (1967) (115)
- Findings from NSABP protocol no. B‐04‐comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome (1980) (115)
- Long-term tamoxifen citrate use and potential ocular toxicity. (1998) (114)
- Comparison of radical mastectomy with alternative treatments for primary breast cancer (1978) (113)
- Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05. (1998) (112)
- The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy (2003) (111)
- Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. (2001) (110)
- Experimental Studies of Factors Influencing Hepatic Metastases (1962) (110)
- New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. (1991) (109)
- Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. (1992) (108)
- Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. (1970) (107)
- Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17: Intraductal carcinoma (ductal carcinoma in situ) (1995) (107)
- Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five‐year treatment failure (1980) (106)
- Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. (1987) (103)
- Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. (1977) (103)
- Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. (1995) (100)
- DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S‐Phase fraction to outcome of patients in NSABP B‐04 (1991) (100)
- Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer. (2004) (99)
- Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer (1977) (98)
- The organ distribution of disseminated 51 Cr-labeled tumor cells. (1967) (97)
- Pathologic findings from the national surgical adjuvant breast project. (Protocol no. 4). III. The significance of extranodal extension of axillary metastases. (1976) (96)
- Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma (2005) (95)
- Pathologic findings from the national surgical adjuvant breast and bowel projects (NSABP) prognostic discriminants for 8‐year survival for node‐negative invasive breast cancer patients (1990) (95)
- Local therapy and survival in breast cancer. (2007) (89)
- Relation of estrogen and its receptor to rat liver growth and regeneration. (1984) (88)
- Experimental studies of factors influencing hepatic metastases. II. Effect of partial hepatectomy (1959) (85)
- The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal. (1970) (83)
- Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. (2003) (82)
- Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. (2004) (80)
- Prognosis among African‐American women and white women with lymph node negative breast carcinoma (1997) (77)
- Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells (1974) (76)
- Pathologic variables predictive of breast events in patients with ductal carcinoma in situ. (2007) (74)
- Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. (2001) (73)
- The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival. (1983) (72)
- Effect of increased hepatic blood flow upon liver regeneration. (1954) (72)
- Systemic therapy in node-negative patients: updated findings from NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project. (1992) (71)
- Studies concerning the regional lymph node in cancer. II. Maintenance of immunity (1972) (69)
- Breast-Cancer Management (1979) (69)
- Evaluation of a humoral factor in liver regeneration utilizing liver transplants. (1971) (69)
- Biological research in the evolution of cancer surgery: a personal perspective. (2008) (66)
- Tumor size and regional lymph node metastasis in colorectal cancer a preliminary analysis from the NSABP clinical trials (1983) (66)
- Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23 (2004) (65)
- A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer (1977) (64)
- Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis. (1978) (63)
- Tamoxifen for the prevention of breast cancer. (2000) (63)
- Dukes' classification revisited. Findings from the national surgical adjuvant breast and bowel projects (protocol r‐01) (1989) (62)
- The relationship of depth of penetration and tumor size to the number of positive nodes in dukes C colorectal cancer (1984) (62)
- Duration of adjuvant tamoxifen therapy. (2001) (62)
- The evolution of breast cancer surgery: past, present, and future. (1978) (62)
- Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). (1986) (61)
- Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer. (1976) (61)
- Studies concerning the regional lymph node in cancer. III. Response of regional lymph node cells from breast and colon cancer patients to PHA stimulation (1972) (58)
- Experimental studies of factors influencing hepatic metastases. I. The effect of number of tumor cells injected and time of growth (1959) (58)
- Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation (1986) (57)
- Glycogen-rich, clear cell breast cancer: with comments concerning other clear cell variants. (1985) (56)
- Barrier function of lymph node to tumor cells and erythrocytes. II. Effect of x‐ray, inflammation, sensitization and tumor growth (1967) (55)
- The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice. (1974) (54)
- Correlation of primary breast cancer histopathology and estrogen receptor content (1981) (53)
- Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors (1987) (52)
- Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer (1999) (52)
- Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. (1986) (52)
- Role of murine tumor models in cancer treatment research. (1986) (51)
- S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer (2004) (50)
- Liver regeneration following portacaval shunt. (1962) (49)
- Experimental studies of factors which influence hepatic metastases. VII. Efect of anticoagulants. (1961) (48)
- Lobular carcinoma of the breast: an overview. (1977) (48)
- The technique of segmental mastectomy (lumpectomy) and axillary dissection: A syllabus from the National Surgical Adjuvant Breast Project workshops. (1987) (48)
- Pathologic findings from the national surgical adjuvant breast project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation (1983) (47)
- Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project. (1998) (47)
- Studies concerning the regional lymph node in cancer. VII. Thymidine uptake by cells from nodes of breast cancer patients relative to axillary location and histopathologic discriminants (1974) (45)
- Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. (1989) (45)
- Experiences with bilateral primary carcinoma of the breast. (1973) (45)
- Studies concerning the regional lymph node in cancer. VI. Correlation of lymphocyte transformation of regional node cells and some histopathologic discriminants (1973) (44)
- Anticoagulants and tumor cell lodgement. (1967) (44)
- Cooperative clinical trials in primary breast cancer: A critical appraisal (1973) (44)
- Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes. (1983) (42)
- EXPERIMENTAL STUDY OF FACTORS INFLUENCING DEVELOPMENT OF HEPATIC METASTASES FROM CIRCULATING TUMOR CELLS. (1965) (42)
- Disease‐free survival at intervals during and following completion of adjuvant chemotherapy: The NSABP experience from three breast cancer protocols (1981) (42)
- Tumor Cell Cytotoxicity by Granulocytes From Peripheral Blood of Tumor-Bearing Mice (1978) (41)
- ULTRASTRUCTURAL HEPATIC CHANGES FOLLOWING PARTIAL HEPATECTOMY AND PORTACAVAL SHUNT IN THE RAT. (1963) (40)
- The breast cancer alternative hypothesis: is there evidence to justify replacing it? (2010) (39)
- Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents. (1975) (39)
- INVESTIGATIONS CONCERNING THE ROLE OF A HUMORAL FACTOR IN LIVER REGENERATION. (1963) (38)
- Fluoresceinated estrone binding by human and mouse breast cancer cells. (1982) (38)
- Location of breast carcinoma and prognosis. (1969) (37)
- New concepts in the management of primary breast cancer (1975) (37)
- Prognostic factors in NSABP studies of women with node-negative breast cancer. National Surgical Adjuvant Breast and Bowel Project. (1992) (36)
- Value of assessment of ploidy in rectal cancers. (1989) (36)
- Comparison of Concomitant and Sinecomitant Tumor Immunity 1 (1970) (36)
- Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer. (1992) (36)
- The intestine as a source of a portal blood factor responsible for liver regeneration. (1973) (36)
- National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary. (1999) (35)
- Experimental evaluation of prolonged hypothermia. (1955) (34)
- Some physiologic effects of short- and long-term hypothermia upon the liver. (1956) (34)
- The Prognostic Significance of Tumor Location and Bowel Obstruction in Dukes B and C Colorectal Cancer (1983) (34)
- Fraud in breast-cancer trials. (1994) (33)
- Effects of X‐irradiation on parameters of tumor growth, histology, and ultrastructure (1969) (33)
- Medullary cancer of the breast revisited (1990) (33)
- Adjuvant Therapy for Node-Negative Breast Cancer (1989) (33)
- Occurrence of stroke with tamoxifen in NSABP B-24 (2000) (32)
- Types of tumor lymphoid response and sinus histiocytosis. Relationship to five-year, disease-free survival in patients with breast cancer. (1983) (32)
- Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). (1989) (32)
- ROLE OF MAST CELLS IN TUMOR GROWTH. (1965) (32)
- A comparison of stapled and handsewn anastomoses in patients undergoing resection for Dukes' B and C colorectal cancer (1986) (32)
- Surgical adjuvant therapy for breast cancer (1972) (32)
- Relative prognostic value of the Dukes and the Jass systems in rectal cancer (1989) (32)
- Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer (2005) (32)
- Physiologic observations related to the transurethral resection reaction. (1962) (31)
- OBSERVATIONS ON THE EOSINOPHIL COUNT IN MAN A PROPOSED TEST OF ADRENAL CORTICAL FUNCTION (1951) (31)
- Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective. (2008) (31)
- The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice. (1974) (31)
- Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice. (1974) (31)
- Role of science in the treatment of breast cancer when tumor multicentricity is present. (2011) (30)
- EXPERIMENTAL STUDIES OF FACTORS INFLUENCING THE DEVELOPMENT OF HEPATIC METASTASES. XIII. EFFECT OF HEPATIC TRAUMA IN PARABIOTIC PAIRS. (1963) (29)
- Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. (1981) (29)
- Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients. (1996) (29)
- Effect of Antilymphocyte Serum on Parameters of Growth of MCA-induced Tumours (1969) (29)
- Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0) (2007) (29)
- Observations on liver blood flow; its relationship to cardiac output in anesthetized and unanesthetized animals. (1956) (28)
- Experimental evaluation of liver atrophy and portacaval shunt. (1967) (28)
- Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancer (1969) (28)
- Electron microscopic, histologic, and histochemical features of the Walker carcinoma. (1961) (27)
- Recent observations on concepts of metastasis. (1967) (27)
- Rarity of hepatic metastases in cirrhosis--a misconception. (1960) (27)
- Conservative surgery: the American experience. (1986) (27)
- Evaluation of the worth of Corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer: Eight‐year results from the national surgical adjuvant breast and bowel project B‐10 (1990) (27)
- Pathologic and histochemical observations in experimental hypothermia. (1957) (26)
- The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth. (1976) (26)
- Effect of Antilymphocyte Serum on Parameters of Tumor Growth in a Syngeneic Tumor-Host System∗ (1969) (25)
- Tissue mast cells in breast cancer (2005) (25)
- Clinical trials for the evaluation of cancer therapy (1984) (25)
- Studies concerning the regional lymph node in cancer. V. Histologic and ultrastructural findings in regional and nonregional nodes. (1973) (25)
- Lumpectomy and axillary dissection for breast cancer: Surgical, pathological, and radiation considerations (1985) (25)
- Preoperative chemotherapy for operable breast cancer. (2000) (25)
- Reappraisal of breast biopsy prompted by the use of lumpectomy. Surgical strategy. (1985) (25)
- Status of adjuvant therapy. Results of the national surgical adjuvant breast project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Other comments concerning clinical trials (1971) (25)
- Significance of the interrelationship of the lymph and blood vascular systems in tumor cell dissemination. (1970) (24)
- Experimental studies of factors influencing hepatic metastases. IV. Effect of cirrhosis (1960) (23)
- Temperature gradients associated with extracorporeal perfusion and profound hypothermia. (1961) (23)
- The favorable effect of pyridoxine deficiency on skin homograft survival. (1958) (23)
- Observations concerning bacterial defense mechanisms during hypothermia. (1958) (22)
- Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed. (1974) (22)
- Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism. (1976) (22)
- Interrelation between tumor cell proliferation and 17-fluoresceinated estrone binding following primary tumor removal, radiation, cyclophosphamide, or tamoxifen. (1983) (21)
- Arteriovenous fistula and bacterial endocarditis. (1962) (21)
- Influence of irradiation of a primary tumor on the labeling index and estrogen receptor index in a distant tumor focus. (1986) (21)
- The efficacy of bone scanning in the follow-up of patients with operable breast cancer (2005) (21)
- Rewarming following hypothermia of two to twelve hours. II. Some metabolic effects. (1958) (20)
- Correlation of ultrastructure and function following hypothermic preservation of canine kidneys. (1967) (20)
- Therapy of breast cancer (1978) (20)
- The revolution in breast cancer surgery: Science or anecdotalism? (1985) (20)
- Experimental studies of factors influencing hepatic metastases. VII. Effect of reticuloendothelial interference. (1961) (19)
- Effect of Hypothermia upon Induced Bacteremia.∗ (1956) (19)
- The effect of alteration of liver blood flow upon experimental hepatic metastases. (1961) (19)
- The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer: Results from NSABP Clinical Trials (1984) (19)
- Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy (2005) (19)
- Observations on the effect of neuraminidase on the distribution of intravenously injected walker tumor cells in rats (1974) (19)
- On the underutilization of breast-conserving surgery for the treatment of breast cancer. (1993) (18)
- Personal contributions to progress in breast cancer research and treatment. (1996) (18)
- Characterization of mammotrophs separated from the human pituitary gland. (1976) (18)
- Further experimental observations on animals with arterialized livers. (1955) (18)
- Relationship of pathologic and some clinical discriminants to the spread of breast cancer. (1977) (18)
- Lumpectomy versus quadrantectomy for breast conservation: a critical appraisal. (1995) (18)
- Studies concerning the regional lymph node in cancer VIII. Effect of two asynchronous tumor foci on lymph node cell cytotoxicity (1975) (18)
- A biological perspective of breast cancer: Contributions of the national surgical adjuvant breast and bowel project clinical trials (1991) (18)
- The present status of tumor immunology. (1971) (18)
- Simultaneous determination of blood volume with Cr51 and T-1824 during hypothermia and rewarming. (1959) (17)
- Experimental studies of factors influencing hepatic metastases. VI. Effect of nutrition (1961) (17)
- Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity. (1976) (17)
- Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation (1986) (17)
- The place of neck dissection in the management of parotid tumors. (1970) (16)
- Scar cancers: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) — IX (2005) (16)
- Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice. (1979) (16)
- Physiologic effect of massive small intestinal resection and colostomy. (1950) (16)
- Fluoresceinated estrone binding by cells from human breast cancers obtained by needle aspiration (1983) (15)
- Host factors influencing the development of metastases. (1962) (15)
- Cytoplasmic liver cell inclusions following arterialization in the dog. (1954) (15)
- Rewarming Following Hypothermia of Two to Twelve Hours: I. Cardiovascular Effects (1958) (15)
- Effect of hypothermia of 2 to 24 hours on oxygen consumption and cardiac output in the dog. (1957) (15)
- Local lymphoid response as an index of tumor immunity. (1972) (15)
- Thyroid and parathyroid implantation: an experimental re-evaluation. (1967) (15)
- The Changing Role of Surgery in the Treatment of Cancer (1977) (14)
- LOCAL FACTORS AFFECTING TUMOR GROWTH. I. EFFECT OF TISSUE HOMOGENATES. (1963) (14)
- Sounding board. Breast-cancer management: alternatives to radical mastectomy. (1979) (14)
- The effect of a growing tumor and its removal on the cytotoxicity of macrophages from cultured bone marrow cells. (1976) (14)
- Experimental studies of factors influencing hepatic metastases. V. Effect of cortisone and adrenalectomy. (1960) (14)
- Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition. (1970) (14)
- Further observations on the inhibition of tumor growth by corynebacterium parvum with cyclophosphamide. (1976) (14)
- Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (1998) (13)
- Experiences with lymphocyte immunotherapy in experimental tumor systems (1971) (13)
- Role of host and tumor calcium in metastases. (1968) (13)
- A suitable technique for total arterialization of the dog liver. (1954) (12)
- Hepatic damage by reticuloendothelial interference. (1963) (12)
- Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation (1978) (12)
- The dissemination of subcutaneously inoculated tumor cell suspensions. (1969) (12)
- Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. II. Effect of cortisone acetate. (1976) (12)
- Effect of Corynebacterium parvum on liver proliferation and regeneration. (1979) (12)
- Biologic aspects of cancer-cell spread. (1964) (12)
- Surgery of Primary Breast Cancer (1977) (12)
- Experimental studies of factors influencing hepatic metastases. X. Effect of reticuloendothelial stimulation. (1962) (12)
- Biologic considerations regarding the one and two step procedures in the management of patients with invasive carcinoma of the breast. (1985) (12)
- Response—blunting the counterpoint (1995) (12)
- Intestinal Absorption and Nitrogen Balance Following Portacaval Shunt (1968) (11)
- Adjuvant therapy in node-negative breast cancer (1989) (11)
- Circulating cancer cells and metastases. (1975) (11)
- PROLONGED SURVIVAL OF SKIN HOMOGRAFTS IN DOGS WITH THORACIC DUCT FISTULA. (1963) (11)
- Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide. (1978) (11)
- The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines. (1991) (11)
- Adjuvant chemotherapy in the primary management of breast cancer. (1977) (10)
- Some thoughts concerning the primary therapy of breast cancer. (1976) (10)
- Arterial portography: indications and technique. (1967) (10)
- Experimental studies of factors influencing hepatic metastases. XVI. Rheologic alterations. (1966) (10)
- IS TAMOXIFEN A RISK FACTOR FOR RETINAL VASO-OCCLUSIVE DISEASE? (2005) (10)
- Nodular goiter and carcinoma of the thyroid. (1951) (10)
- ROLE OF THYMUS IN SKIN AND TUMOR TRANSPLANTATION IN THE RAT. (1965) (9)
- A commentary on the role of the surgeon in primary breast cancer (2005) (9)
- Further observations on skin homografts in pyridoxine deficient animals. (1962) (9)
- Impact of randomized clinical trials on therapy of primary breast cancer: the NSABP overview. (1982) (9)
- Alteration of the effects of jejuno-colic fistula: an experimental study. (1962) (9)
- The effect of induced arteriosclerosis on fresh and lyophilized aortic homografts in the rabbit. (1956) (9)
- The interrelationship of hematogenous and lymphatic tumor cell dissemination: an experimental study. (1966) (9)
- TISSUE TRANSPLANTATION AND THE RETICULOENDOTHELIAL SYSTEM I. Effect of Skin Grafts in Normal Animals (1964) (9)
- Tumor specificity, serum inhibition, and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow. (1977) (9)
- The regional lymph node in cancer. Relationship of nodal histologic findings to cytotoxicity and immunity. (1977) (9)
- Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model. (1978) (8)
- Relation of a recurrent intraductal carcinoma (ductal carcinoma in situ) to the primary tumor. (2000) (8)
- Results of Investigations with Corynebacterium parvum in an Experimental Animal System (1975) (8)
- One Giant Leap for Mankind (1973) (8)
- Observations concerning spleen homotransplantation in normal and irradiated animals. (1961) (8)
- Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. (1987) (8)
- NSABP Protocol B-06: A randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer — Results after 15 years of follow-up (1998) (8)
- Effect on permanent alteration of hepatic blood flow upon biliary secretion. (1958) (8)
- Glomerular lipoidosis in the dog. (1954) (8)
- Tamoxifen Use , and Outcomes in Women With Estrogen Receptor – Positive Early-Stage Breast Cancer (2003) (8)
- Surgery in the primary treatment of breast cancer (2005) (8)
- Justification for lumpectomy in the treatment of breast cancer: a commentary on the underutilization of that procedure. (1992) (7)
- Serum growth factor following primary tumor removal and the inhibition of its production by preoperative therapy. (1990) (7)
- Adjuvant chemotherapy for breast cancer: an overview of NSABP findings. (1982) (7)
- THE BIOLOGY OF METASTASES. (1965) (7)
- Composition of the regenerated dog liver following partial hepatectomy and total arterialization. (1955) (7)
- Limited surgical management for primary breast cancer: A commentary on the NSABP reports (1985) (7)
- THYROPARATHYROID HOMOTRANSPLANTATION BY VASCULAR ANASTOMOSIS. EFFECT OF IMMUNOSUPPRESSIVE DRUGS. (1964) (7)
- Clinical trials and the surgical treatment of breast cancer. (1978) (7)
- Surgical treatment of primary breast cancer. (1988) (7)
- Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim report (2005) (7)
- Rewarming Following Hypothermia of Two to Twelve Hours (1958) (7)
- RESPONSE: Re: Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study (2006) (7)
- Adjuvant tamoxifen and chemotherapy in stage II breast cancer: Interim findings from NSABP protocol B-09 (1985) (6)
- RENAL HOMOTRANSPLANTATION IN NEONATAL THYMECTOMIZED PUPPIES (1965) (6)
- Experimental Factors Influencing Hepatic Metastases. XII. Effect of Increased Arterial Blood Flow.∗ (1963) (6)
- Experimental Studies of Factors Influencing Hepatic Metastases: IX. The Pituitary Gland (1961) (6)
- Spirogermanium: Effects on Hematopoietic Stem Cells and Survival of Normal and Tumor-Bearing Mice 1 (1983) (6)
- Antilymphocyte serum and allogeneic inhibition. (1970) (6)
- Histopathologic and ultrastructural study of allogeneic hepatic transplantation in isogenic rats. (1970) (6)
- Experimental Studies of Factors Influencing Hepatic Metastases: XI. Effect of Hepatic Trauma in Hypophysectomized Animals.∗ (1962) (6)
- The hepatotoxic effect of nitrogen mustard after direct intraportal injection (1956) (6)
- Re: tamoxifen prevention of breast cancer: an instance of the fingerpost. (2000) (6)
- The operative management of primary breast cancer. (1977) (6)
- Adjuvant therapy in primary breast cancer. (1985) (6)
- Systemic Adjuvant (Combined Modality) Therapy in the Treatment of Primary Breast Cancer (1977) (5)
- Observations using diodrast 1131 as an index of renal function in auto- and homotransplantation. (1960) (5)
- Lack of Thymic Effect on Wound Healing.∗ (1965) (5)
- The use of radioactive iodine labeled triolein in the evaluation of fat absorption following cholecystectomy. (1960) (5)
- Adjuvant chemotherapy in breast cancer. (1978) (5)
- The sterilization and storage of lyophilized blood vessels. (1956) (5)
- Surgery for early breast cancer. (1996) (5)
- Experimental studies of factors influencing hepatic metastases. XV. Effect of neonatal thymectomy. (1965) (5)
- Present status of the management of regional lymph nodes and planned clinical trials. (1971) (5)
- Adjuvant chemotherapy in stage II breast cancer: A brief overview of the NSABP clinical trials (1985) (5)
- Investigation of Rejection of Canine Renal Homotransplants by Fluorescent Antibody Technic.∗ (1959) (5)
- Adjuvant chemotherapy in stage-II breast cancer: An overview of the NSABP clinical trials (2005) (5)
- United States trials of conservative surgery (1977) (5)
- The significance of concordance in mammographic interpretations (1979) (4)
- EXPERIMENTAL STUDIES OF FACTORS INFLUENCING HEPATIC METASTASES. XIV. EFFECT OF PROLACTIN. (1963) (4)
- EFFECT OF EXPERIMENTAL PERFUSION UPON THE BIOLOGIC AND PATHOLOGIC BEHAVIOR OF TUMOR. (1964) (4)
- Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice. (1979) (4)
- Effect of Tumor Cell Inoculation on Circulating Lymphocytes 1 (1972) (4)
- Further observations on the role of bile in the pathogenesis of pancreatitis. (1953) (4)
- Experimental Studies of Factors Influencing Hepatic Metastases. XVIII. Significance of Trapped Tumor Cells.∗ (1967) (4)
- Experimental study of relationship between hypertension and tumor growth and metastases. (1968) (4)
- Effect of low molecular weight dextran on hepatic metastases in the rabbit. (1968) (4)
- Experimental studies of factors influencing development of hepatic metastases. XVII. Role of thyroid. (1966) (4)
- Nor-epinephrine Cells of Adrenal Medulla Following Hypothermia and Unilateral Adrenalectomy (1955) (4)
- Redmond C & Others for the National Surgical Adjuvant Breast and Bowel Project (1994) (4)
- Pattern of regional failure in patients with breast cancer treated by lumpectomy, breast radiation +/− chemotherapy and/or tamoxifen with no regional radiation: results from 10 NSABP randomized trials (2003) (4)
- Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy. (1986) (4)
- The current status of systemic adjuvant therapy in the management of primary breast cancer. (1981) (4)
- Study of the Cardioplegic Action of Potassium Ion During Normothermia and Hypothermia (1959) (3)
- Variation of macrophage migration by a factor from regional lymph node cells of breast cancer patients (1978) (3)
- A comparison of two and three years of adjuvant tamoxifen. (1989) (3)
- The clinical scientific basis of adjuvant chemotherapy in breast cancer. (1984) (3)
- A biological basis for the surgical treatment of clinically curable breast cancer. (1972) (3)
- Effect of the number of injections of antigen on the effectiveness of antilymphocyte serum. (1969) (3)
- Skin homografts in pyridoxine-deficient humans. (1959) (3)
- Alteration of the Effects of Jejuno‐Colic Fistula: An Experimental Study (1962) (3)
- Influence of Different Carriers Upon the Cardioplegic Activity of Potassium Ion (1962) (3)
- A vignette from breast cancer history: one hundred years after the Greenough report. (2005) (3)
- Cardiac Temperature Gradients During Profound Hypothermia with Extracorporeal Perfusion.∗ (1961) (3)
- Tamoxifen a nd C hemotherapy f or A xillary N ode-Negative, Estrogen R eceptor-Negativ e B reast C ancer: F indings F rom National S urgical A djuvant B reast a nd B owel P roject B -23 (2001) (3)
- Chemotherapy and tamoxifen for breast cancer. (1981) (3)
- An evaluation of the liver‐stimulating effect of serum and plasma from patients with cancer (1964) (3)
- TISSUE TRANSPLANTATION AND THE RETICULOENDOTHELIAL SYSTEM II. Effect of Vitamin B Deficiency on Phagocytic Activity (1964) (3)
- Optimal surgical approaches to the local management of early breast cancer (1985) (3)
- Primary breast cancer: some considerations concerning its management. (1971) (3)
- A brief overview of findings from NSABP trials of adjuvant therapy. (1984) (3)
- Stressor effect of hypothermia in the rat. (1957) (3)
- Nephrotoxic Serum Nephritis in Thymectomized Rats.∗ (1964) (3)
- Prevention of fibrillation during hypothermia by pericardial space perfusion. (1958) (2)
- Idiopathic megaduodenum; report of a case. (1948) (2)
- Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction. (1978) (2)
- Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt. (1979) (2)
- Antinuclear Factor in Sensitized Lymph and Serum from Skin Homografted Dogs.∗ (1963) (2)
- Cellular cytotoxicity and serum inhibition in normal mice following transfer of syngeneic tumor-sensitized cells. (1980) (2)
- S21 Preoperative therapy (PROP) for breast cancer (1998) (2)
- Current Controversies in Cancer Tamoxifen for the prevention of breast cancer (2000) (2)
- Observations on prolonged hypothermia in the dog. (1955) (2)
- Effect of partial hepatectomy, protein realimentation, and bile refeeding on biliary secretion in the rat. (1953) (2)
- COMMENT ON: TAMOXIFEN AND CHEMOTHERAPY FOR LYMPH NODE-NEGATIVE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER. AUTHORS' REPLY (1998) (2)
- The fate of autogenous skin tubes as aorta grafts. (1956) (2)
- Herniation of the rectum following coccygectomy. (1951) (2)
- Case report of a lethal cardiac toxic effect following high-dose cyclophosphamide. (1995) (2)
- Antilymphocyte, serum enhances incidence, growth and metastasis of transplanted tumors (1969) (2)
- Antilymphocyte Serum In Nephrotoxic Serum Nephritis 1 (1970) (2)
- Adjuvant therapy in node-negative breast cancer (1989) (2)
- Cellular cytotoxicity and serum inhibition in normal mice following transfer of xenogeneic tumor-sensitized cells. (1979) (2)
- Figure 118.15, [Growth regulation of breast cancer...]. (2000) (2)
- Experimental reconstruction of the aortic bifurcation. (1956) (2)
- United States trials of adjuvant therapy (1977) (1)
- Surgical Oncology—Definition, History, Scope, Philosophy (2011) (1)
- The interrelationship of hematogenous and lymphatic tumor cell disemination: an experimental study. (1966) (1)
- DCIS: evidence from radomized trials (2003) (1)
- Tumor and host calcium in human colon carcinoma (1970) (1)
- EFFECT OF PYRIDOXINE DEFICIENCY ON RENAL HOMOTRANSPLANTATION IN PUPPIES. (1963) (1)
- Contributions to the understanding and management of breast cancer. Steiner award lecture 1992 (1993) (1)
- Lymphoid Index in Allogeneic Inhibition 1 (1972) (1)
- ANTINUCLEAR FACTOR IN SENSITIZED LYMPH AND SERUM FROM SKIN HOMOGRAFTED DOGS. (1964) (1)
- Tumor cells cytotoxicity by granulocytes from peripheral blood of tumor-bearing mice. (1978) (1)
- A Personal Perspective About the Future of Breast Cancer Research and Treatment (2000) (1)
- Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII. (1978) (1)
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer (2023) (1)
- Antiprolactin and Experimentally-Induced Hepatic Metastases.∗ (1966) (1)
- Effect of reticuloendothelial interference on experimental metastases. (1960) (1)
- Potassium ion as a cardioplegic agent in total cardiac bypass and during hypothermia with coronary perfusion: an experimental study. (1960) (1)
- Successful management of infantile diarrhea in a general hospital. (1950) (1)
- ROLE OF MAST CELLS IN HOMOGRAFT REACTION. (1964) (1)
- Effectof Corynebacteriumparvumon Liver Proliferationand Regeneration1 (1979) (1)
- Concerning the Management of Breast Cancer (1970) (1)
- The effect of prolonged hypothermia on oxygen consumption of the liver slice. (1956) (1)
- Management of primary cancer of the breast. New considerations. (1975) (1)
- [The NSABP. National Surgical Adjuvant Project for Breast and Bowel Cancers. (Definition, role, methodology, therapeutic trials, results, philosophy)]. (1985) (1)
- Re : Benzene and the Dose-Related Incidence of Hematologic Neoplasms in China (1998) (1)
- Leukemia in Breast Cancer Patients Following Adjuvant Chemotherapy or Postoperative Radiation (2016) (1)
- Answers to questions about breast cancer. (1986) (0)
- Tamoxifen for intraductal cancer (1999) (0)
- Effect of prolonged Corynebacterium parvum and cyclophosphamide administration on spontaneously occurring metastases. (1975) (0)
- The significance of regional lymph node cell mediated cytotoxicity in the response of a murine adenocarcinoma to chemoimmunotherapy. Abstr. (1983) (0)
- Seminars in Breast Disease: Introduction (2004) (0)
- Tamoxi fen , Radiat ion Therapy , or Both for Prevent ion of Ips i la tera l Breast Tumor Recurrence Af ter Lumpectomy in Women With Invas ive Breast Cancers of One Cent imeter or Less (2002) (0)
- TAMOXIFEN FOR INTRADUCTAL CANCER. AUTHORS' REPLY (1999) (0)
- New concepts in the treatment of breast cancer. (1981) (0)
- Endometrial cancer deaths in tamoxifen-treated breast cancer patients (1996) (0)
- An overview of the breast protocols of NSAPB. (1982) (0)
- Proceedings: Cooperative clinical trials in primary breast cancer: a critical appraisal. (1972) (0)
- Prolonging Tamoxifen Therapy for Primary Breast Cancer (2020) (0)
- Differences in esophageal cancer treatments. (1996) (0)
- Combination of loco-regional and systemic therapy in the treatment of primary breast cancer. (1977) (0)
- 16th annual San Antonio breast cancer symposium November 5-6, 1993 (2004) (0)
- Mammographic density and obesity as risk factors for invasive breast cancer following ductal carcinoma in situ (DCIS) (2003) (0)
- Demographic characteristics and quality of life factors among the participants of the breast cancer prevention trial (1998) (0)
- Tamoxifen added to lumpectomy and radiation therapy reduced breast cancer events in ductal carcinoma in situ (2000) (0)
- Juvant Tamoxifen Therapy for Breast Cancer. Note (0)
- TRANSITION TO MEDICATION INDEPENDENCE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (2006) (0)
- The electrolyte pattern following total hepatectomy. (1953) (0)
- TISSUE TRANSPLANT (1962) (0)
- Effect of fibrinolytic agents on the thrombosis rate of prosthetic grafts in small arteries: an experimental study. (1961) (0)
- Progress in the treatment of breast cancer. Invited commentary. (1977) (0)
- BLOOD VESSELS SURGERY AND ITS COMPLICATIONS (reprint) (1961) (0)
- Invited commentary (1977) (0)
- Hepatic blood flow studies in animals with totally arterialized livers. (1955) (0)
- Breast‐Conserving Surgery in the Treatment of Invasive Breast Cancer: Its Validity and Outstanding Issues (1995) (0)
- Vincristine is Associated with the Risk of Azoospermia in Adult Male Survivors of Childhood Malignancies (1992) (0)
- REWARMING FOLLOWING PROLONGED HYPOTHERMIA (1957) (0)
- REWARMING FOLLOWING HYPOTHERMIA OF TWO TO TWELVE HOURS II (1959) (0)
- Tamoxifen and Retinal Vaso–Occlusive Disease (2004) (0)
- A safe inexpensive x-ray and fluoroscopic table for the dog laboratory. (1955) (0)
- A gas-type heat exchanger for induction of profound hypothermia and rewarming. (1962) (0)
- Mesenteric thrombosis. (1948) (0)
- Comment on: Tamoxifen for the prevention of breast cancer : Current status of the national surgical adjuvant breast and bowel project P-1 study. Authors' reply (2006) (0)
- The fate of potassium as a cardioplegic agent in normothermic animals. (1958) (0)
- Renal homotransplantation in puppies. (1962) (0)
- METASTASES IN PARABIOTIC ANIMALS FOLLOWING LIVER INJURY. (1963) (0)
- Role of Host and Tumor Calcium in Métastases1 (2006) (0)
- Tumor metastasis of mammary carcinoma to the lung reflected in an in vitro chemotaxis assay of bone marrow cells from c3h mice. Abstr. (1981) (0)
- Biological Implications of Breast Cancer Surgery (1986) (0)
- Abstracts reprinted from journal of clinical oncology (2007) (0)
- Response to Arnold (1994) (0)
- Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells. (1980) (0)
- Augmentation of cell mediated cytotoxicity (cmc) in tumor bearing mice following transfer of tumor sensitized spleen cells (tssc). Abstr. (1981) (0)
- Fluoresceinated Estrone Binding by Normal and Neoplastic Cells of Human and Animal Origin (2019) (0)
- Statistical approaches for relating end results to amount of drug received in breast cancer therapy trials (1981) (0)
- The status of estrogen receptor of breast cancer cells. (1985) (0)
- COMMON ON: FIVE VERSUS MORE THAN FIVE YEARS OF TAMOXIFEN THERAPY FOR BREAST CANCER PATIENTS WITH NEGATIVE LYMPH NODES AND ESTROGEN RECEPTOR-POSITIVE T UMORS. AUTHOR'S REPLY (1997) (0)
- Cirrhosis \p=m-\A Misconception (2017) (0)
- 1963. Prolonged survival of skin homografts in dogs with thoracic duct fistulas (1965) (0)
- The status of estrogen receptor of breast cancer cell. Quantitative analysis of estrogen receptor status in fluoresceinated breast cancer cells. (1985) (0)
- Antilymphocyte Serum and Allogeneic Inhibition 1 (2006) (0)
- 10-Year survival from cancer in Umbria, Italy (1994) (0)
This paper list is powered by the following services:
Other Resources About Bernard Fisher
What Schools Are Affiliated With Bernard Fisher ?
Bernard Fisher is affiliated with the following schools:
